Glaucoma News

  • AAO 2018 Drug Pipeline for Macular Degeneration in Focus at AAO Updates from phase 3 trials of VEGF inhibitors for neovascular age-related macular degeneration, and a novel genetic treatment, will be highlighted at the American Academy of Ophthalmology meeting.
  • Non-White Elders in U.S. Less Likely to Use Low-Vision Devices Older white people with very impaired eyesight are more likely to use low-vision devices that may improve independence, compared to elderly people in other racial and ethnic groups, a U.S. study suggests.

Glaucoma Perspective